Stock BMRN BIOMARIN PHARMACEUTICAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders BioMarin Pharmaceutical Inc.

Equities

BMRN

US09061G1013

Real-time Estimate Cboe BZX
Other stock markets
 07:40:37 18/06/2024 pm IST 		5-day change 1st Jan Change
85.02 USD 0.00% Intraday chart for BioMarin Pharmaceutical Inc. +1.92% -11.35%
10/06 Texas Pacific Land, Altair Engineering Hit 52-Week Highs on S&P MidCap 400 Inclusion DJ
10/06 KKR & Co, CrowdStrike, GoDaddy to Join S&P 500 Index on June 24 MT

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
BioMarin Pharmaceutical Insider Sold Shares Worth $3,043,802, According to a Recent SEC Filing
MT
Biomarin Pharmaceutical Insider Sold Shares Worth $3,255,200, According to a Recent SEC Filing
MT
Biomarin Pharmaceutical Insider Sold Shares Worth $414,550, According to a Recent SEC Filing
MT
Biomarin Pharmaceutical Insider Sold Shares Worth $3,645,000, According to a Recent SEC Filing
MT
Biomarin Pharmaceutical Insider Sold Shares Worth $2,173,341, According to a Recent SEC Filing
MT
Biomarin Pharmaceutical Insider Sold Shares Worth $348,280, According to a Recent SEC Filing
MT
BioMarin Pharmaceutical Appoints Cristin Hubbard as Chief Commercial Officer
MT
Biomarin Announces Board Changes, Effective May 20, 2024
CI
Biomarin Pharmaceutical Inc. Announces Resignation of Jeffrey Ajer as Executive Vice President and Chief Commercial Officer, Effective from July 1, 2024
CI
Biomarin Pharmaceutical Insider Sold Shares Worth $1,945,700, According to a Recent SEC Filing
MT
Biomarin Pharmaceutical Insider Sold Shares Worth $939,900, According to a Recent SEC Filing
MT
BioMarin Pharmaceutical Inc. Announces Board Appointments, Effective December 27, 2023
CI
Biomarin Pharmaceutical Insider Sold Shares Worth $1,311,709, According to a Recent SEC Filing
MT
Activist investor Elliott targets drugmaker BioMarin -sources
RE
Biomarin Pharmaceutical Inc. Announces CEO Changes
CI
Biomarin Pharmaceutical Inc. Announces Executive Changes
CI
Insider Sell: Biomarin Pharmaceutical
MT
Insider Sell: Biomarin Pharmaceutical
MT
Insider Sell: Biomarin Pharmaceutical
MT
Insider Sell: Biomarin Pharmaceutical
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BMRN Stock
  4. News BioMarin Pharmaceutical Inc.
  5. Insiders